{"id":105386,"date":"2013-02-05T23:50:20","date_gmt":"2013-02-05T22:50:20","guid":{"rendered":"http:\/\/www.pcnen.com\/portal\/?p=105386"},"modified":"2013-02-05T23:50:20","modified_gmt":"2013-02-05T22:50:20","slug":"nova-vakcina-za-lijecenje-raka-pluca-u-fazi-testiranja","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2013\/02\/05\/nova-vakcina-za-lijecenje-raka-pluca-u-fazi-testiranja\/","title":{"rendered":"Nova vakcina za lije\u010denje raka plu\u0107a u fazi testiranja"},"content":{"rendered":"<p>Francuska farmaceutska kompanija OP (Ose Pharma) je saop\u0161tila da se nova vakcina za lije\u010denje raka plu\u0107a trenutno nalazi u fazi testiranja.<\/p>\n<p>Francuski nau\u010dnici se pripremaju za uvo\u0111enje ove nove terapije u tre\u0107u fazu ispitivanja, \u0161to zna\u010di da \u0107e vakcina biti testirana na dobrovoljcima oboljelima od raka plu\u0107a kako bi bila utvr\u0111ena njena prava djelotvornost.<\/p>\n<p>OP planira narednih dana da organizuje prikupljanje pet miliona eura koji \u0107e omogu\u0107iti sprovo\u0111enje faze testiranja u Evropi i SAD.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Francuska farmaceutska kompanija OP (Ose Pharma) je saop\u0161tila da se nova vakcina za lije\u010denje raka plu\u0107a trenutno nalazi u fazi testiranja.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-105386","post","type-post","status-publish","format-standard","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/105386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=105386"}],"version-history":[{"count":0,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/105386\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=105386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=105386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=105386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}